133 related articles for article (PubMed ID: 22723462)
1. DNAzyme targeting c-jun suppresses skin cancer growth.
Cai H; Santiago FS; Prado-Lourenco L; Wang B; Patrikakis M; Davenport MP; Maghzal GJ; Stocker R; Parish CR; Chong BH; Lieschke GJ; Wong TW; Chesterman CN; Francis DJ; Moloney FJ; Barnetson RS; Halliday GM; Khachigian LM
Sci Transl Med; 2012 Jun; 4(139):139ra82. PubMed ID: 22723462
[TBL] [Abstract][Full Text] [Related]
2. Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function.
Khachigian LM; Cai H; Moloney FJ; Parish CR; Chong BH; Stocker R; Barnetson RS; Halliday GM
Oncotarget; 2012 Jun; 3(6):594-5. PubMed ID: 22805148
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression.
Zhang G; Luo X; Sumithran E; Pua VS; Barnetson RS; Halliday GM; Khachigian LM
Oncogene; 2006 Nov; 25(55):7260-6. PubMed ID: 16785994
[TBL] [Abstract][Full Text] [Related]
4. Dz13: c-Jun downregulation and tumour cell death.
Elahy M; Dass CR
Chem Biol Drug Des; 2011 Dec; 78(6):909-12. PubMed ID: 21722318
[TBL] [Abstract][Full Text] [Related]
5. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents.
Zhang G; Dass CR; Sumithran E; Di Girolamo N; Sun LQ; Khachigian LM
J Natl Cancer Inst; 2004 May; 96(9):683-96. PubMed ID: 15126605
[TBL] [Abstract][Full Text] [Related]
6. Melanoma protective antitumor immunity activated by catalytic DNA.
Cai H; Cho EA; Li Y; Sockler J; Parish CR; Chong BH; Edwards J; Dodds TJ; Ferguson PM; Wilmott JS; Scolyer RA; Halliday GM; Khachigian LM
Oncogene; 2018 Sep; 37(37):5115-5126. PubMed ID: 29844573
[TBL] [Abstract][Full Text] [Related]
7. c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model.
Dass CR; Khachigian LM; Choong PF
Mol Cancer Res; 2008 Aug; 6(8):1289-92. PubMed ID: 18708361
[TBL] [Abstract][Full Text] [Related]
8. Tetrahedral DNA Nanostructure-Delivered DNAzyme for Gene Silencing to Suppress Cell Growth.
Meng L; Ma W; Lin S; Shi S; Li Y; Lin Y
ACS Appl Mater Interfaces; 2019 Feb; 11(7):6850-6857. PubMed ID: 30698411
[TBL] [Abstract][Full Text] [Related]
9. Dz13, a DNAzyme targeting c-jun, induces off-target cytotoxicity in endothelial cells with features of nonapoptotic programmed cell death.
Gozar MM; Goodchild A; Passioura T; King A; Lai A; Witherington C; Rivory L
Oligonucleotides; 2008 Sep; 18(3):257-68. PubMed ID: 18699742
[TBL] [Abstract][Full Text] [Related]
10. Dz13 induces a cytotoxic stress response with upregulation of E2F1 in tumor cells metastasizing to or from bone.
Dass CR; Tan ML; Galloway SJ; Choong PF
Oligonucleotides; 2010 Apr; 20(2):79-91. PubMed ID: 20406096
[TBL] [Abstract][Full Text] [Related]
11. Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun.
Fahmy RG; Waldman A; Zhang G; Mitchell A; Tedla N; Cai H; Geczy CR; Chesterman CN; Perry M; Khachigian LM
Nat Biotechnol; 2006 Jul; 24(7):856-63. PubMed ID: 16823369
[TBL] [Abstract][Full Text] [Related]
12. Sequence-related off-target effect of Dz13 against human tumor cells and safety in adult and fetal mice following systemic administration.
Dass CR; Choong PF
Oligonucleotides; 2010 Apr; 20(2):51-60. PubMed ID: 20148692
[TBL] [Abstract][Full Text] [Related]
13. DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells.
Liang Z; Wei S; Guan J; Luo Y; Gao J; Zhu H; Wu S; Liu T
J Gastroenterol Hepatol; 2005 Oct; 20(10):1595-602. PubMed ID: 16174080
[TBL] [Abstract][Full Text] [Related]
14. Induction of caspase-2 activation by a DNA enzyme evokes tumor cell apoptosis.
Kim SH; Dass CR
DNA Cell Biol; 2012 Jan; 31(1):1-7. PubMed ID: 22077397
[TBL] [Abstract][Full Text] [Related]
15. The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity.
Rivory L; Tucker C; King A; Lai A; Goodchild A; Witherington C; Gozar MM; Birkett DJ
Oligonucleotides; 2006; 16(4):297-312. PubMed ID: 17155906
[TBL] [Abstract][Full Text] [Related]
16. Resurrecting DNAzymes as sequence-specific therapeutics.
Rossi JJ
Sci Transl Med; 2012 Jun; 4(139):139fs20. PubMed ID: 22723461
[TBL] [Abstract][Full Text] [Related]
17. Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation.
Dass CR; Galloway SJ; Choong PF
Oligonucleotides; 2010 Jun; 20(3):137-46. PubMed ID: 20180631
[TBL] [Abstract][Full Text] [Related]
18. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).
Cho EA; Moloney FJ; Cai H; Au-Yeung A; China C; Scolyer RA; Yosufi B; Raftery MJ; Deng JZ; Morton SW; Hammond PT; Arkenau HT; Damian DL; Francis DJ; Chesterman CN; Barnetson RS; Halliday GM; Khachigian LM
Lancet; 2013 May; 381(9880):1835-43. PubMed ID: 23660123
[TBL] [Abstract][Full Text] [Related]
20. Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer.
Qu Y; Zhang L; Mao M; Zhao F; Huang X; Yang C; Xiong Y; Mu D
Cancer Gene Ther; 2008 Aug; 15(8):517-25. PubMed ID: 18404163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
